Search results
Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus
Zacks via Yahoo Singapore Finance· 6 months agoXenon (XENE) reports mixed fourth-quarter 2023 financial results, wherein earnings beat estimates...
12 Most Profitable Biotech Stocks To Invest In
Insider Monkey via Yahoo Singapore Finance· 6 months agoIn this piece, we will take a look at the 12 most profitable biotech stocks to invest in. If you want to skip our overview of the global biotechnology...
OmniAb Inc (OABI) Reports Decline in Annual Revenue and Net Loss for Q4 and Full Year 2023
GuruFocus.com via Yahoo Singapore Finance· 6 months agoRevenue: Q4 revenue fell to $4.8 million from $35.3 million in the same period last year, largely...
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst...
Benzinga via Yahoo Singapore Finance· 2 weeks agoWednesday, Neurocrine Biosciences, Inc. (NASDAQ: NBIX) topline data for its Phase 2 clinical study...
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
MediaOutReach via Yahoo Singapore Finance· 6 months agoCloud endoscopy system using NTT's high-speed, low-latency IOWN APN technologyHighlights: NTT's IOWN...
Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results
GuruFocus.com via Yahoo Singapore Finance· 6 months agoFinancial Position: Strong with approximately $930 million in cash, supporting operations into 2027. Research and Development: Increased to $167.5 million in 2023, up from $105.8 million in ...
Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings: Strong Revenue Growth and Strategic Advancements
GuruFocus.com via Yahoo Singapore Finance· 4 months agoTotal Revenue: Reported at $515.3 million for Q1 2024, up from $420.4 million in Q1 2023, surpassing estimates of $511.97 million. Net Income: Shifted to a GAAP net income of $43.4 million in ...
The Most Respected Country in The World
Insider Monkey via Yahoo Singapore Finance· 2 months agoThis article will reveal the most respected country in the world. Check out our full list of Most Respected Countries in the World. The Role of Political...
Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Singapore Finance· 4 months agoINGREZZA Sales: $506 million in Q1, 20% year-over-year growth. Net Income: Significant year-over-year operating leverage, non-GAAP basis over 1,000 basis points excluding prior year IP R&D investments ...
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 10 months agoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Q3 2023 Earnings Call Transcript October 31, 2023...
